Overview 3-year Follow-up Study to Assess the Viral Activity in Hepatitis C Patients Who Failed Feeder DEB025/Alisporivir Study Status: Terminated Trial end date: 2014-01-23 Target enrollment: Participant gender: Summary Follow-up for viral activity, changes in liver function and safety in patients with no SVR24 in feeder studies Phase: Phase 3 Details Lead Sponsor: Novartis Pharmaceuticals